Novavax to Present at the 14th Annual Needham Healthcare Conference
(Thomson Reuters ONE) -
GAITHERSBURG, Md., April 8, 2015 (GLOBE NEWSWIRE) -- Novavax, Inc.,
(Nasdaq:NVAX) a clinical-stage vaccine company focused on the discovery,
development and commercialization of recombinant nanoparticle vaccines and
adjuvants, today announced Stanley C. Erck, President and Chief Executive
Officer, will present at the 14(th) Annual Needham Healthcare Conference at
8:00 a.m. ET, April 15, 2015 in New York City at the Westin Grand Central Hotel.
A live webcast link for the presentation will be available via the company
website at www.novavax.com under Investor Info/Events.
About Novavax
Novavax, Inc. (Nasdaq:NVAX) is a clinical-stage vaccine company committed to
delivering novel products to prevent a broad range of infectious diseases. Its
recombinant nanoparticles and Matrix-M(TM) adjuvant technology are the
foundation for ground-breaking innovation that improves global health through
safe and effective vaccines. Additional information about Novavax is available
on the company's website, www.novavax.com.
CONTACT: Novavax, Inc.
Barclay A. Phillips
SVP, Chief Financial Officer and Treasurer
Andrea N. Flynn, Ph.D.
Senior Manager, Investor Relations
ir(at)novavax.com
240-268-2000
Russo Partners, LLC
David Schull
Todd Davenport, Ph.D.
david.schull(at)russopartnersllc.com
todd.davenport(at)russopartnersllc.com
212-845-4271
This announcement is distributed by GlobeNewswire on behalf of
GlobeNewswire clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Novavax, Inc. via GlobeNewswire
[HUG#1909301]
Unternehmensinformation / Kurzprofil:
Datum: 08.04.2015 - 22:02 Uhr
Sprache: Deutsch
News-ID 384441
Anzahl Zeichen: 2219
contact information:
Town:
Maryland
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 110 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Novavax to Present at the 14th Annual Needham Healthcare Conference"
steht unter der journalistisch-redaktionellen Verantwortung von
Novavax, Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
